Different medical institutions have selected different imported and domestic brand instruments: 38 domestic and 58 imported.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Recently, the strategic business matchmaking meeting between Jointown medical devices group co., ltd. and Mindray was held in Shenzhen.

Recently, COVID-19 (SARS-CoV-2) Antigen Test Kit independently developed by Wuhan Easy Diagnosis passed the performance verification of Paul-Ehrlich-Institut in Germany.

Recently, Roche Diagnostics and Yunkang Group officially announced that they had reached further strategic cooperation.

At present, six new COVID-19 antigen (home-use) kits have been authorized for emergency use by BfArM. The certification means that the product can be sold in German supermarkets, and local residents can use the product for self-testing.

Recently, a number of Chinese listed IVD companies released 2020 annual performance report, disclosing their revenue. Driven by the demand of testing products of COVID-19, the performance growth is very gratifying.

On the evening of February 19, FTSE Russell, an international index compilation company, announced the quarterly review results of its flagship index, adding 129 A-share targets in total. Edan Instruments (300206. SZ) officially entered the

As of February 20, 2021, FDA has urgently authorized 14 COVID-19 antigen tests, involving 11 companies: Abbott、Ortho、Quidel 、BD、LumiraDx、Access Bio、Princeton BioMeditech、Luminostics、Celltrion、Quanterix、Ellume.

Recently， there are many IVD companies that complete the financing, including Ustar, GENFINE BIOTECH, Accunome, Legendaibiochip and Vision Medicals.

On February 18, 2021, New Horizon Health was officially listed on HK stock exchange.

Find out what is going on in Chinese in vitro diagnostic industry